Evidence map›Paper›PMID 38298725›Full record

ArticleHeliyon2024

Deep learning-assisted survival prognosis in renal cancer: A CT scan-based personalized approach.

Maryamalsadat Mahootiha, Hemin Ali Qadir, Davit Aghayan, Åsmund Avdem Fretland, Bjørn von Gohren Edwin, Ilangko Balasingham

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maryamalsadat MahootihaThe Intervention Centre, Oslo University Hospital, Oslo, 0372, Norway.
Hemin Ali QadirThe Intervention Centre, Oslo University Hospital, Oslo, 0372, Norway.
Davit AghayanThe Intervention Centre, Oslo University Hospital, Oslo, 0372, Norway.
Åsmund Avdem FretlandThe Intervention Centre, Oslo University Hospital, Oslo, 0372, Norway.
Bjørn von Gohren EdwinThe Intervention Centre, Oslo University Hospital, Oslo, 0372, Norway.
Ilangko BalasinghamThe Intervention Centre, Oslo University Hospital, Oslo, 0372, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents a deep learning (DL) approach for predicting survival probabilities of renal cancer patients based solely on preoperative CT imaging. The proposed approach consists of two networks: a classifier- and a survival- network. The classifier attempts to extract features from 3D CT scans to predict the ISUP grade of Renal cell carcinoma (RCC) tumors, as defined by the International Society of Urological Pathology (ISUP). Our classifier is a 3D convolutional neural network to avoid losing crucial information on the interconnection of slides in 3D images. We employ multiple procedures, including image augmentation, preprocessing, and concatenation, to improve the performance of the classifier. Given the strong correlation between ISUP grading and renal cancer prognosis in the clinical context, we use the ISUP grading features extracted by the classifier as the input to the survival network. By leveraging this clinical association and the classifier network, we are able to model our survival analysis using a simple DL-based network. We adopt a discrete LogisticHazard-based loss to extract intrinsic survival characteristics of RCC tumors from CT images. This allows us to build a completely parametric survival model that varies with patients' tumor characteristics and predicts non-proportional survival probability curves for different patients. Our results demonstrated that the proposed method could predict the future course of renal cancer with reasonable accuracy from the CT scans. The proposed method obtained an average concordance index of 0.72, an integrated Brier score of 0.15, and an area under the curve value of 0.71 on the test cohorts.

Indexed as

Cancer prognosisDeep learningImaging biomarkersKidney tumor gradingPersonalized prognosisRadiomicsRenal cell carcinomaSurvival analysis

Identifiers

PMID38298725
PMCPMC10828686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.